EMA рекомендувала до схвалення одразу 12 нових лікарських засобів

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…

The company signed an agreement for its Indian business with Premji Invest and SB Packagings. Constantia Flexibles, a leading producer of flexible packaging worldwide, signed a joint venture (JV) agreement…